From the Editors' Desk

  • ACG Worldwide Expands Barrier Film Manufacturing Capacity

    To support the growing need for barrier films worldwide, ACG recently launched a new 200,000 square foot manufacturing facility. The facility in Shirwal, Pune (India) triples ACG Pharmapack's films output while maintaining high quality. The facility is ISO 9001:2000 and ISO 1400:2004 certified, conforms to cGMP norms and is on par with class 100000 guidelines. In addition, ACG Pharmapak has a DMF registration with the US FDA, meets EC norms, has an EMS certification, and is registered with SFDA-China and the Canadian Health Department.
     

  • Needle-free Option for Hemophilia Patients Adds Convenience

    West Pharmaceutical Services Inc. and Grifols USA L.L.C. announce the availability of West’s Mix2Vial filtered transfer system for the reconstitution of Grifols’ coagulation therapies. The Mix2Vial system, developed and manufactured by West’s subsidiary Medimop Medical Projects Ltd., is a patented device designed for easy reconstitution of lyophilized drugs.

  • Alpha Packaging to Be Acquired by Irving Place Capital

    Irving Place Capital (IPC) is announcing that it has agreed to purchase Alpha Packaging (St. Louis, MO), a blow molder of plastic bottles and jars for the nutraceutical, pharmaceutical, and personal care markets. The transaction is expected to close in September of 2010.

    Alpha Packaging manufactures plastic bottles and jars at five U.S. manufacturing facilities and has a new plant in the Netherlands. The company’s Technigraph division provides container decorating services to personal care brands.

  • DuPont to Produce EVA in China

    DuPont is announcing that production for Ethylene Vinyl Acetate (EVA) resins has begun at its joint venture, Beijing Hua Mei Polymer Company Limited, in Beijing. The facility is DuPont’s first operation to make EVA in China. 

  • Global Vaccine Market Expected to Hit $34 Billion By 2012

    With an estimated annual growth rate of 14% during the next five years, vaccines will be one of the fastest-growing therapeutic areas, even outpacing oncology. Vaccines Review and Outlook 2010, PharmaLive’s newest Special Report, examines the reasons behind the growth and the developers/manufacturers, delivery systems, and innovations that are key drivers.